Preoperative bi-fractionated accelerated radiation therapy for combined treatment of locally advanced rectal cancer in a consecutive series of unselected patients
2007

Preoperative Radiation Therapy for Rectal Cancer

Sample size: 47 publication Evidence: moderate

Author Information

Author(s): Biffi Roberto, Marsiglia Hugo, Fossa Barbara Jereczek, Leonardi Maria Cristina, Cante Domenico, Lazzari Roberta, Chiappa Antonio, Cenciarelli Sabine, Andreoni Bruno, Zampino Maria Giulia, Orecchia Roberto

Primary Institution: European Institute of Oncology

Hypothesis

Is preoperative bi-fractionated accelerated radiation therapy safe and effective for treating locally advanced rectal cancer?

Conclusion

Bi-fractionated accelerated radiation therapy is safe and effective for patients with locally advanced rectal cancer, with low toxicity and good long-term survival rates.

Supporting Evidence

  • The 5-year overall survival rate was 74.2%.
  • The disease-free survival rate was 62.9%.
  • The regional control rate was 84.7%.
  • Postoperative complications occurred in 27.6% of patients.
  • Two patients experienced severe grade 4 gastrointestinal toxicity.

Takeaway

Doctors used a special type of radiation therapy before surgery to help patients with rectal cancer, and it worked well with few side effects.

Methodology

Patients with locally advanced rectal cancer received 41.6 Gy of radiation in 26 fractions before surgery, followed by total mesorectal excision.

Potential Biases

Potential selection bias due to the retrospective nature of the study.

Limitations

The study is retrospective and conducted at a single center, which may limit the generalizability of the findings.

Participant Demographics

24 men and 23 women, median age 55 years.

Digital Object Identifier (DOI)

10.1186/1477-7800-4-23

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication